ornithine has been researched along with cardiovascular agents in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emanueli, C; Fortunato, O; Madeddu, P; Mangialardi, G; Monopoli, A; Ongini, E; Spinetti, G | 1 |
| Angelone, T; Cerra, MC; De Francesco, EM; Maggiolini, M; Pasqua, T; Pupo, M | 1 |
| Checa, A; Kövamees, O; Lundberg, JO; Östenson, CG; Pernow, J; Shemyakin, A; Wheelock, CE | 1 |
1 trial(s) available for ornithine and cardiovascular agents
| Article | Year |
|---|---|
Arginase Inhibition Improves Microvascular Endothelial Function in Patients With Type 2 Diabetes Mellitus.
Topics: Acetylcholine; Aged; Arginase; Arginine; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Laser-Doppler Flowmetry; Male; Microvessels; Middle Aged; Nitroprusside; Ornithine; Peripheral Vascular Diseases; Severity of Illness Index; Vascular Resistance; Vasodilation; Vasodilator Agents | 2016 |
2 other study(ies) available for ornithine and cardiovascular agents
| Article | Year |
|---|---|
Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells.
Topics: Aged; Anticholesteremic Agents; Apoptosis; Benzoates; Cardiovascular Agents; Cardiovascular Diseases; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellular Senescence; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Leukocytes, Mononuclear; Male; Middle Aged; Neovascularization, Physiologic; Nitrates; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Ornithine; Proto-Oncogene Proteins c-akt; Pyrroles; Stem Cells | 2011 |
GPER mediates cardiotropic effects in spontaneously hypertensive rat hearts.
Topics: Animals; Benzodioxoles; Cardiovascular Agents; Connective Tissue Growth Factor; Cyclopentanes; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle Relaxation; Nitric Oxide Synthase Type III; Organ Culture Techniques; Ornithine; Proto-Oncogene Proteins c-akt; Quinolines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, G-Protein-Coupled; Signal Transduction | 2013 |